方法对比
并排查看您选择的方法；存在差异的行会高亮显示。
| 临床痴呆评定量表× | 蒙特利尔认知评估× | |
|---|---|---|
| 领域 | 康复 | 康复 |
| 方法族 | Process / pipeline | Process / pipeline |
| 起源年份≠ | 1984 | 2005 |
| 提出者≠ | Morris, John C. | Nasreddine, Phillips, Bédirian |
| 类型≠ | Clinician-rated scale | Cognitive screening test |
| 开创性文献≠ | Morris, J. C. (1993). The Clinical Dementia Rating (CDR): current version and scoring rules. Neurology, 43(11), 2412–2414. DOI ↗ | Nasreddine, Z. S., Phillips, N. A., Bédirian, V., Charbonneau, S., Whitehead, V., Collin, I., ... & Chertkow, H. (2005). The Montreal Cognitive Assessment, MoCA: a brief screening tool for mild cognitive impairment. Journal of the American Geriatrics Society, 53(4), 695–699. DOI ↗ |
| 别名 | CDR, CDR Scale, Washington University Dementia Rating | MoCA, MoCA Test, Montreal Cognitive Assessment Test |
| 相关 | 1 | 1 |
| 摘要≠ | The Clinical Dementia Rating (CDR) is a clinician-administered scale that assesses severity of dementia on a 0–3 scale based on interview with the patient and an informed collateral source (e.g., family member). Developed by Morris and colleagues at Washington University School of Medicine, the CDR has become the reference standard for dementia severity assessment in clinical practice and research, particularly for staging Alzheimer's disease. | The Montreal Cognitive Assessment (MoCA) is a brief 10-minute cognitive screening test designed to detect mild cognitive impairment (MCI) in older adults. Developed by Nasreddine and colleagues in 2005 at McGill University, MoCA is more sensitive to cognitive impairment than the Mini-Cog or MMSE, particularly for detecting early Alzheimer's disease and non-Alzheimer dementias, making it widely used in primary care, neurology, and geriatric medicine. |
| ScholarGate数据集 ↗ |
|
|